In order to determinate whether POU4F2, C1, C2 and C3 can be utilized to diagnose bladder cancer in early-stage, we listed their sensitivities in different sub-categories of bladder cancer patients (Table 5). This evidence concerns the gene POU4F2 and urinary bladder carcinoma.